The protective role of dapagliflozin on the noreflow phenomenon in type 2 diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention

Koseoglu, CemalConer, AliOncel, Can Ramazan2026-01-242026-01-2420250001-53851784-973Xhttps://doi.org/10.1080/00015385.2025.2511523https://hdl.handle.net/20.500.12868/5843[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessThe protective role of dapagliflozin on the noreflow phenomenon in type 2 diabetic patients with acute coronary syndrome undergoing percutaneous coronary interventionLetter10.1080/00015385.2025.2511523805534534404208092-s2.0-105007012268Q3WOS:001497848600001Q2